.jpg?format=webp&width=780)
The American Joint Committee on Cancer (AJCC) periodically revises its staging system for cancer, including appendix cancer, based on new evidence. The latest revision, the ninth edition, incorporated survival analysis using the eighth edition criteria. Based on prognostic differences, the revisions justified separating appendix cancer into three histologies: non-mucinous, mucinous, and signet-ring cell. The staging system highlights the challenges of staging rare tumors and the impact of data limitations on survival analysis for low-grade appendiceal mucinous neoplasms. This article emphasizes the clinical components and insights the version 9 AJCC staging system provides for appendix cancer.
Like
Save
Share